- Johnson & Johnson’s one-dose COVID-19 vaccine appeared safe and effective in trials, the U.S. Food and Drug Administration said Wednesday, paving the way for its approval for emergency use as soon as this week.
Overall, the vaccine was 100% effective at stopping hospitalization 28 days after vaccination, compared with 85% at 14 days, and there were no COVID-19 deaths among those who received the shot rather than a placebo. While the FDA is not bound to follow the advice of its experts, it approved both the Pfizer and Moderna vaccines the day after the advisory committee met.
The J&J vaccine is also considered essential in the global vaccination effort due to its routine storage requirements and is already being rolled out to 500,000 healthcare workers in South Africa. However, he said some public health authorities may ask to see more robust data before being persuaded.
Wish it was more effective than 60% range
Cc YAYshamsaldeen
Developed in Leiden, the Netherlands 👍
iannetts70 non è che dentro c'è dello shampoo
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.